Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by University of Zurich.
Recruitment status was:  Recruiting
Information provided by:
University of Zurich Identifier:
First received: April 8, 2008
Last updated: April 11, 2008
Last verified: April 2008

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

  • Trial with medicinal product

Condition Intervention Phase
Alveolar Echinococcosis
Other: Stop treatment
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Resource links provided by NLM:

Further study details as provided by University of Zurich:

Estimated Enrollment: 30
Study Start Date: January 2008
Estimated Study Completion Date: January 2009

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Study Population
Patients with inoperable alveolar echinococchosis

Inclusion criteria:

  • Patients with inoperable alveolar echinococcosis
  • With negative PET-CT
  • EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria:

  • Positive PET-CT
  • Positive EmII-3-10 Serology
  • No compliance
  • Reduced life expectancy
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00658294

Contact: 01 Studienregister MasterAdmins 41-044-255-1111

University Hospital Zurich Recruiting
Zurich, Switzerland
Contact       Beat.Mü   
Sponsors and Collaborators
University of Zurich
Principal Investigator: Beat Müllhaupt 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Beat Müllhaupt, University Hospital Zurich Identifier: NCT00658294     History of Changes
Other Study ID Numbers: EK-1351
Study First Received: April 8, 2008
Last Updated: April 11, 2008

Additional relevant MeSH terms:
Echinococcosis, Hepatic
Cestode Infections
Parasitic Diseases
Liver Diseases, Parasitic
Liver Diseases
Digestive System Diseases
Antiparasitic Agents
Anti-Infective Agents processed this record on May 23, 2017